Quarterly report · Q1

Period2022-04-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥48.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥184.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥46.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥6.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥5.9bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥8.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥23.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.3bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥8.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥7.6bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.3bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥5.3bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥325.4bnat 2022-06-30Cons.Assets
Total assets¥315.5bnat 2022-03-31Cons.Assets
Total assets¥297.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥72.8bnat 2022-06-30Cons.Liabilities
Total liabilities¥69.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥252.5bnat 2022-06-30Cons.Net assets
Net assets / equity¥246.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥230.8bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥46.5bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥38.5bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥35.412022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.882021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥35.42022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥101.652021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥30.872021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio77.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.2%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 52
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥27m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥473m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥69m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥69m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥1.9bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue2022-04-01 → 2022-06-30¥21.2bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue external2022-04-01 → 2022-06-30¥21.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥12.6bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥12.6bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E00836-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥2.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue external2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥46.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥46.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥42m
—segment totalsegment profit2022-04-01 → 2022-06-30¥7.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥48.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥48.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥69m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥8.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥25m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥444m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥66m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥66m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥1.7bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue2021-04-01 → 2021-06-30¥20.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue external2021-04-01 → 2021-06-30¥20.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥40m
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentsegment profit2021-04-01 → 2021-06-30¥3.4bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E00836-000Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue2021-04-01 → 2021-06-30¥11.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue external2021-04-01 → 2021-06-30¥11.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentsegment profit2021-04-01 → 2021-06-30¥1.8bn
—segment totalrevenue2021-04-01 → 2021-06-30¥44.3bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥44.2bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥40m
—segment totalsegment profit2021-04-01 → 2021-06-30¥7.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥46.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥46.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥66m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥7.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 393
ItemContextValueUnit
Net defined benefit assetCurrentQuarterInstant4630000000JPY
Other ioaPrior1YearInstant4949000000JPY
Other ioaCurrentQuarterInstant4837000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-63000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-63000000JPY
Investments and other assetsPrior1YearInstant42970000000JPY
Investments and other assetsCurrentQuarterInstant41490000000JPY
Noncurrent assetsPrior1YearInstant139616000000JPY
Noncurrent assetsCurrentQuarterInstant139715000000JPY
AssetsPrior1YearInstant315459000000JPY
AssetsCurrentQuarterInstant325364000000JPY
Notes and accounts payable tradePrior1YearInstant18011000000JPY
Notes and accounts payable tradeCurrentQuarterInstant22794000000JPY
Short term loans payablePrior1YearInstant3176000000JPY
Short term loans payableCurrentQuarterInstant3012000000JPY
Current portion of bondsPrior1YearInstant4000000000JPY
Current portion of bondsCurrentQuarterInstant4000000000JPY
Accounts payable otherPrior1YearInstant9617000000JPY
Accounts payable otherCurrentQuarterInstant8748000000JPY
Income taxes payablePrior1YearInstant2997000000JPY
Income taxes payableCurrentQuarterInstant1151000000JPY
Other clPrior1YearInstant7956000000JPY
Other clCurrentQuarterInstant9388000000JPY
Current liabilitiesPrior1YearInstant45760000000JPY
Current liabilitiesCurrentQuarterInstant49095000000JPY
Bonds payablePrior1YearInstant8000000000JPY
Bonds payableCurrentQuarterInstant8000000000JPY
Long term loans payablePrior1YearInstant1474000000JPY
Long term loans payableCurrentQuarterInstant1446000000JPY
Net defined benefit liabilityPrior1YearInstant380000000JPY
Net defined benefit liabilityCurrentQuarterInstant401000000JPY
Other nclPrior1YearInstant13419000000JPY
Other nclCurrentQuarterInstant13895000000JPY
Noncurrent liabilitiesPrior1YearInstant23273000000JPY
Noncurrent liabilitiesCurrentQuarterInstant23744000000JPY
LiabilitiesPrior1YearInstant69034000000JPY
LiabilitiesCurrentQuarterInstant72839000000JPY
Capital stockPrior1YearInstant14932000000JPY
Capital stockCurrentQuarterInstant14932000000JPY
Capital surplusPrior1YearInstant15759000000JPY
Capital surplusCurrentQuarterInstant15772000000JPY
Retained earningsPrior1YearInstant195566000000JPY
Retained earningsCurrentQuarterInstant197317000000JPY
Treasury stockPrior1YearInstant-2624000000JPY
Treasury stockCurrentQuarterInstant-2624000000JPY
Shareholders equityPrior1YearInstant223633000000JPY
Shareholders equityCurrentQuarterInstant225397000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant9818000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant8894000000JPY
Foreign currency translation adjustmentPrior1YearInstant10630000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass